L’hôpital Saint-Jacques est le deuxième plus ancien des sept établissements hospitaliers gérés par le centre hospitalier universitaire de la ville de Nantes, en France, sur le territoire de laquelle il est implanté. Il se situe le long de la rive gauche de la Loire, dans le quartier Nantes Sud.

During the past decade, HOP Saint-Jacques conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "HOP Saint-Jacques" are "Depressive Disorder, Major" (1 trials) and "Schizophrenia" (1 trials). Many other conditions were trialed in "HOP Saint-Jacques" in a lesser frequency.

Most popular intervention types in "HOP Saint-Jacques" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BI 1358894" (1 trials), "BI 425809" (1 trials) and "Quetiapine" (1 trials). Other intervention names were less common.

The vast majority of trials in "HOP Saint-Jacques" are 2 trials for "All" genders.

Currently, there are NaN active trials in "HOP Saint-Jacques". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in HOP Saint-Jacques, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in HOP Saint-Jacques, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".